CEL-SCI CORPORATION Accounts Payable
CEL-SCI CORPORATION (CVM) had Accounts Payable of $1.02 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $1.02M.
- 2026-03-31: Accounts Payable, Current $933.79K.
- 2025-12-31: Accounts Payable, Current $1.03M.
- 2025-09-30: Accounts Payable, Current $1.06M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $1.02M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $933.79K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.03M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $1.06M 10-Q · filed 2026-08-14 |
| 2025-06-30 | $1.58M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.70M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.00M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $1.45M 10-K · filed 2025-12-29 |
| 2024-06-30 | $1.37M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.02M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.14M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $2.01M 10-K · filed 2025-01-13 |
| 2023-06-30 | $1.74M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.89M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $1.60M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $1.62M 10-K · filed 2023-12-21 |
| 2022-06-30 | $852.86K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.32M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.19M 10-Q · filed 2022-02-11 |
| 2021-09-30 | $1.68M 10-K · filed 2022-12-27 |
| 2021-06-30 | $2.14M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $2.39M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $3.09M 10-Q · filed 2021-02-12 |
| 2020-09-30 | $2.02M 10-K · filed 2021-12-21 |
| 2020-06-30 | $943.82K 10-Q/A · filed 2020-12-31 |
| 2020-03-31 | $1.14M 10-Q/A · filed 2020-12-30 |
| 2019-12-31 | $1.44M 10-Q/A · filed 2020-12-30 |
| 2019-09-30 | $1.59M 10-Q/A · filed 2020-12-31 |
| 2019-06-30 | $2.08M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $4.16M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $4.90M 10-Q · filed 2019-02-14 |
| 2018-09-30 | $5.74M 10-K/A · filed 2019-12-23 |
| 2018-06-30 | $6.25M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $7.69M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $7.87M 10-Q · filed 2018-02-12 |
| 2017-09-30 | $8.20M 10-K · filed 2018-12-19 |
| 2017-06-30 | $8.35M 10-Q/A · filed 2017-12-11 |
| 2017-03-31 | $7.07M 10-Q/A · filed 2017-12-11 |
| 2016-12-31 | $2.74M 10-Q/A · filed 2017-12-11 |
| 2016-09-30 | $3.09M 10-K · filed 2017-12-29 |
| 2016-06-30 | $4.44M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $3.77M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $3.86M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $5.13M 10-K/A · filed 2017-12-11 |
| 2015-06-30 | $3.16M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $1.70M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $1.64M 10-Q · filed 2015-02-06 |
| 2014-09-30 | $1.16M 10-K · filed 2015-12-11 |
| 2014-06-30 | $1.36M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $1.35M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.63M 10-Q · filed 2014-02-10 |
| 2013-09-30 | $1.92M 10-K · filed 2014-12-23 |
| 2013-06-30 | $1.18M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $465.82K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $410.25K 10-Q · filed 2013-02-08 |
| 2012-09-30 | $592.87K 10-K · filed 2013-12-27 |
| 2012-06-30 | $702.69K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $708.09K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $631.92K 10-Q · filed 2012-02-09 |
| 2011-09-30 | $738.95K 10-K · filed 2012-12-14 |
| 2011-06-30 | $1.27M 10-Q · filed 2011-08-09 |
| 2010-09-30 | $1.50M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |